This post hoc analysis of a trial by our study group [15] found that IL-6, LDH, and lymphocyte count had outstanding discriminative abilities over different COVID-19 clinical milestones, which is consistent with findings from several other reviews [18,19]. The gene discussed is IL6; the disease is COVID-19.